Company Filing History:
Years Active: 1993-1995
Title: Sejiro Minamoto: Innovator in Recombinant Protein Receptors
Introduction
Sejiro Minamoto is a prominent inventor based in Minou, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant protein receptors. With a total of 2 patents to his name, Minamoto's work has the potential to impact various therapeutic applications.
Latest Patents
Minamoto's latest patents focus on recombinant protein receptors for interleukin-2 (IL-2). The first patent is directed to the recombinant IL-21R.beta. chain or fragments thereof. This invention includes cDNA coding for the IL-21R.beta., vectors containing this cDNA, hosts transfected by these vectors, and monoclonal antibodies to the recombinant IL-2R.beta. or its fragments. The second patent pertains to the recombinant IL-2R.mu. protein or fragments thereof, which also includes cDNA coding, vectors, hosts, and monoclonal antibodies related to the encoded recombinant IL-2R.mu. protein.
Career Highlights
Sejiro Minamoto is currently associated with Boehringer Ingelheim International GmbH, where he continues to advance his research in biotechnology. His work is characterized by a commitment to innovation and excellence in the field.
Collaborations
Minamoto has collaborated with notable scientists such as Tadatsugu Taniguchi and Masanori Hatakeyama. These collaborations have further enriched his research and contributed to the advancement of recombinant protein technologies.
Conclusion
Sejiro Minamoto is a distinguished inventor whose work in recombinant protein receptors is paving the way for new therapeutic solutions. His contributions to biotechnology are noteworthy and continue to inspire future innovations.